Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
5 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Editorial Comment: The Time Is Almost Ripe to Mainstream Diffusion in Routine
Breast MRI.
AJR Am J Roentgenol. 2023 Nov 1. doi: 10.2214/AJR.23.30445.
PubMed
Retained Biopsy Site Markers After Breast Lesion Surgical Resection: Associations
With Residual Malignancy.
AJR Am J Roentgenol. 2024;222:e2329670.
PubMed
Abstract available
Editorial Comment: Artificial Intelligence May Help Define Screening Strategies
in Patients With Dense Breasts.
AJR Am J Roentgenol. 2024;222:e2330042.
PubMed
Screening in Patients With Dense Breasts: Comparison of Mammography, Artificial
Intelligence, and Supplementary Ultrasound.
AJR Am J Roentgenol. 2023 Jul 26. doi: 10.2214/AJR.23.29655.
PubMed
Abstract available
Beyond the AJR: Patient Cost-Sharing Adversely Affects Adherence to Downstream
Imaging After Mammography Screening.
AJR Am J Roentgenol. 2023 May 31. doi: 10.2214/AJR.23.29685.
PubMed
Expanding Access to Immediate Lymphatic Reconstruction Through an Axillary
Surgery Referral Program: A 6-Year Single-Center Experience.
Ann Surg Oncol. 2024;31:2025-2031.
PubMed
Abstract available
Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in
Males: An NCDB Analysis of the Surgical Approach to DCIS in Males.
Ann Surg Oncol. 2024;31:1599-1607.
PubMed
Abstract available
Reply to: "Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70
Years of Age? A National Cancer Database Analysis of Sentinel Node Practice
Patterns.
Ann Surg Oncol. 2024;31:1669-1670.
PubMed
Prevention of Seroma Formation and Its Sequelae After Axillary Lymph Node
Dissection: An Up-to-Date Systematic Review and Guideline for Surgeons.
Ann Surg Oncol. 2024;31:1643-1652.
PubMed
Abstract available
ASO Visual Abstract: Oncologic Outcomes in Nipple-Sparing Mastectomy with
Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in
Women with Breast Cancer: A Machine Learning Analysis.
Ann Surg Oncol. 2024 Feb 8. doi: 10.1245/s10434-024-14982.
PubMed
ASO Visual Abstract: Nationwide Analysis of Locoregional Management for Ductal
Carcinoma In Situ (DCIS) in Males-An NCDB Analysis of the Surgical Approach to
DCIS in Males.
Ann Surg Oncol. 2024;31:1663-1664.
PubMed
Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary
Approach.
Ann Surg Oncol. 2024;31:2032-2040.
PubMed
Abstract available
Patient-Reported Outcomes in Patients Undergoing Lumpectomy With and Without
Defect Closure.
Ann Surg Oncol. 2024;31:1615-1622.
PubMed
Abstract available
Sonographic Assessment of Breast Implants Using Strain Elastography and Shear
Wave Elastography in an Animal Model.
Anticancer Res. 2024;44:497-501.
PubMed
Abstract available
A promising target for breast cancer: B7-H3.
BMC Cancer. 2024;24:182.
PubMed
Abstract available
Drug-resistant profiles of extracellular vesicles predict therapeutic response in
TNBC patients receiving neoadjuvant chemotherapy.
BMC Cancer. 2024;24:185.
PubMed
Abstract available
Efficacy and safety analysis of hypofractionated and conventional fractionated
radiotherapy in postoperative breast cancer patients.
BMC Cancer. 2024;24:181.
PubMed
Abstract available
Experiences and perceptions of men following breast cancer diagnosis: a mixed
method systematic review.
BMC Cancer. 2024;24:179.
PubMed
Abstract available
Atypia detected during breast screening and subsequent development of cancer:
observational analysis of the Sloane atypia prospective cohort in England.
BMJ. 2024;384:e077039.
PubMed
Abstract available
Antibodies toward Na(+),HCO(3)(-)-cotransporter NBCn1/SLC4A7 block net acid
extrusion and cause pH-dependent growth inhibition and apoptosis in breast
cancer.
Br J Cancer. 2024 Feb 3. doi: 10.1038/s41416-024-02591.
PubMed
Abstract available
Survival trends and patient characteristics between 2004 and 2016 for breast
cancer in Japan based on the National Clinical Database-Breast Cancer Registry.
Breast Cancer. 2024 Feb 6. doi: 10.1007/s12282-024-01545.
PubMed
Abstract available
Advances in the study of autophagy in breast cancer.
Breast Cancer. 2024 Feb 5. doi: 10.1007/s12282-023-01541.
PubMed
Abstract available
Expression and clinical significance of hypoxia-induced long non-coding RNA
TCONS_I2_00001955 in breast cancer.
Breast Cancer. 2024 Feb 4. doi: 10.1007/s12282-023-01540.
PubMed
Abstract available
Improving lesion detection in mammograms by leveraging a Cycle-GAN-based lesion
remover.
Breast Cancer Res. 2024;26:21.
PubMed
Abstract available
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast
cancer growth.
Breast Cancer Res. 2024;26:23.
PubMed
Abstract available
Low-dose acetylsalicylic acid reduces local inflammation and tissue perfusion in
dense breast tissue in postmenopausal women.
Breast Cancer Res. 2024;26:22.
PubMed
Abstract available
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early
HER2-positive breast cancer.
Breast Cancer Res. 2024;26:24.
PubMed
Abstract available
Are better AI algorithms for breast cancer detection also better at predicting
risk? A paired case-control study.
Breast Cancer Res. 2024;26:25.
PubMed
Abstract available
Comparison of long-term oncological outcomes after central lumpectomy versus
nipple-sparing breast-conserving surgery for centrally located breast cancer: a
propensity score-matched study.
Breast Cancer Res Treat. 2024 Feb 8. doi: 10.1007/s10549-024-07267.
PubMed
Abstract available
Real-world treatment patterns and clinical outcomes in patients treated with
eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic
breast cancer.
Breast Cancer Res Treat. 2024 Feb 4. doi: 10.1007/s10549-023-07080.
PubMed
Abstract available
Investigating the role of tumour-to-skin proximity in predicting nodal metastasis
in breast cancer.
Breast Cancer Res Treat. 2024 Feb 3. doi: 10.1007/s10549-023-07230.
PubMed
Abstract available
Idiopathic Granulomatous Mastitis.
Breast J. 2024;2024:6693720.
PubMed
Abstract available
Gut microbiome in association with chemotherapy-induced toxicities among patients
with breast cancer.
Cancer. 2024 Feb 6. doi: 10.1002/cncr.35229.
PubMed
Abstract available
Trajectories of health-related quality of life and symptom burden in patients
with advanced cancer towards the end of life: Longitudinal results from the
eQuiPe study.
Cancer. 2024;130:609-617.
PubMed
Abstract available
Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer
patients; a prospective clinical study.
Cancer Chemother Pharmacol. 2024 Feb 7. doi: 10.1007/s00280-023-04620.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the
UK Biobank.
Cancer Epidemiol Biomarkers Prev. 2024;33:333-336.
PubMed
Abstract available
Increase in the Life Expectancy of Patients with Cancer in the United States.
Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
PubMed
Abstract available
Glutamine transporter SLC38A3 promotes breast cancer metastasis via
Gsk3beta/beta-catenin/EMT pathway.
Cancer Lett. 2024 Feb 1:216653. doi: 10.1016/j.canlet.2024.216653.
PubMed
Abstract available
Oncolytic virus-based combination therapy in breast cancer.
Cancer Lett. 2024 Feb 1:216634. doi: 10.1016/j.canlet.2024.216634.
PubMed
Abstract available
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in
HER2-positive breast cancer.
Cancer Res. 2024 Feb 6. doi: 10.1158/0008-5472.CAN-23-2812.
PubMed
Abstract available
A metabolic-epigenetic mechanism directs cell fate and therapeutic sensitivity in
breast cancer.
Cancer Res. 2024 Feb 8. doi: 10.1158/0008-5472.CAN-24-0460.
PubMed
Abstract available
Advocating for Enhanced Patient Engagement in Breast Cancer Care: Impact of
Residual Increased Lateral Adiposity and Consideration of the Pursuit of "Living
Flat".
Clin Breast Cancer. 2024 Jan 17:S1526-8209(24)00003.
PubMed
Abstract available
Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone
Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far?
Clin Breast Cancer. 2024 Jan 16:S1526-8209(24)00002.
PubMed
Abstract available
Analysis of Immune Resistance Mechanisms in TNBC: Dual Effects Inside and Outside
the Tumor.
Clin Breast Cancer. 2024;24:e91-e102.
PubMed
Abstract available
Treatments and Prognosis of the Breast Ductal Carcinoma In Situ.
Clin Breast Cancer. 2024;24:122-130.
PubMed
Abstract available
Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery
Outshines Mastectomy in Overall Survival.
Clin Breast Cancer. 2024;24:85-92.
PubMed
Abstract available
The Implication of Growth Arrest-Specific 5 rs145204276 Polymorphism and Serum
Expression of Sirtuin 1, Transforming Growth Factor-Beta, and microRNA-182 in
Breast Cancer.
Clin Med Insights Oncol. 2024;18:11795549241227415.
PubMed
Abstract available
Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and
recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant
chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy
in breast cancer"
Eur J Cancer. 2024 Feb 2:113559. doi: 10.1016/j.ejca.2024.113559.
PubMed
Multiplexed high-throughput immune cell imaging in patients with high-risk triple
negative early breast cancer: Analysis from the International Breast Cancer Study
Group (IBCSG) Trial 22-00.
Eur J Cancer. 2024;200:113535.
PubMed
Abstract available
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer
(BROCADE3): Final overall survival results from a randomized phase 3 trial.
Eur J Cancer. 2024;200:113580.
PubMed
Abstract available
Association of peritumoral region features assessed on breast MRI and prognosis
of breast cancer: a systematic review and meta-analysis.
Eur Radiol. 2024 Feb 9. doi: 10.1007/s00330-024-10612.
PubMed
Abstract available
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in
early HER2-positive breast cancer using a novel deep learning radiomics model.
Eur Radiol. 2024 Feb 8. doi: 10.1007/s00330-024-10609.
PubMed
Abstract available
Can digital breast tomosynthesis decrease interval cancers in a breast cancer
screening program?
Eur Radiol. 2024 Feb 6. doi: 10.1007/s00330-024-10635.
PubMed
Contrast-enhanced mammography: better with AI?
Eur Radiol. 2024;34:914-916.
PubMed
Evaluation of standard breast ultrasonography by adding two-dimensional and
three-dimensional shear wave elastography: a prospective, multicenter trial.
Eur Radiol. 2024;34:945-956.
PubMed
Abstract available
Breast elastography: how does it works, and for what purposes?
Eur Radiol. 2024;34:928-929.
PubMed
Age-related phenotypes in breast cancer: A population-based study.
Int J Cancer. 2024 Feb 6. doi: 10.1002/ijc.34863.
PubMed
Abstract available
Circulating levels of biomarkers and risk of ductal carcinoma in situ of the
breast in the UK Biobank study.
Int J Cancer. 2024;154:1191-1203.
PubMed
Abstract available
GBP2 enhances paclitaxel sensitivity in triple?negative breast cancer by
promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR
pathway.
Int J Oncol. 2024;64:34.
PubMed
Abstract available
Frequency of radiotherapy-induced malignancies in Li-Fraumeni Syndrome patients
with early-stage breast cancer and influence of the radiotherapy technique.
Int J Radiat Oncol Biol Phys. 2024 Feb 1:S0360-3016(24)00249.
PubMed
Abstract available
Molecular Imaging in Breast Cancer: Martine Piccart and Geraldine Gebhart Talk
with David Mankoff About 2 Generations of Research.
J Nucl Med. 2024 Feb 8:jnumed.124.267461. doi: 10.2967/jnumed.124.267461.
PubMed
Phase II Trial Assessing the Repeatability and Tumor Uptake of [(68)Ga]Ga-HER2
Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
J Nucl Med. 2024;65:178-184.
PubMed
Abstract available
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for
prevention of highly emetogenic chemotherapy-induced nausea and vomiting in
patients with solid tumours: a single-centre, open-label, non-inferiority,
randomised, controlled,
Lancet Oncol. 2024;25:246-254.
PubMed
Abstract available
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as
first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:13.
PubMed
Obesity-associated epigenetic alterations and the obesity-breast cancer axis.
Oncogene. 2024 Feb 3. doi: 10.1038/s41388-024-02954.
PubMed
Abstract available
Tumor circadian clock strength influences metastatic potential and predicts
patient prognosis in luminal A breast cancer.
Proc Natl Acad Sci U S A. 2024;121:e2311854121.
PubMed
Abstract available
Impact of a Categorical AI System for Digital Breast Tomosynthesis on Breast
Cancer Interpretation by Both General Radiologists and Breast Imaging
Specialists.
Radiol Artif Intell. 2024 Feb 7:e230137. doi: 10.1148/ryai.230137.
PubMed
Abstract available
Assessment of Feasibility and Interscan Variability of Short-time Cardiac MRI for
Cardiotoxicity Evaluation in Breast Cancer.
Radiol Cardiothorac Imaging. 2024;6:e220229.
PubMed
Abstract available
Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography
System.
Radiol Imaging Cancer. 2024;6:e230020.
PubMed
Abstract available
Low-Dose Positron Emission Mammography: A Novel, Promising Technique for Breast
Cancer Detection.
Radiol Imaging Cancer. 2024;6:e240006.
PubMed
Shared decision making with breast cancer patients - does it work? Results of the
cluster-randomized, multicenter DBCG RT SDM trial.
Radiother Oncol. 2024 Feb 3:110115. doi: 10.1016/j.radonc.2024.110115.
PubMed
Abstract available
Thank you for your interest in scientific medicine.